Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
Juan Decara(Instituto de Investigación Biomédica de Málaga), Antonia Serrano(Instituto de Salud Carlos III)
Cited by 22
Related Papers
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
|Frontiers in Pharmacology|2020|192
Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity
|Nutrients|2021|24
Activation of PI3K/Akt Signaling Pathway in Rat Hypothalamus Induced by an Acute Oral Administration of D-Pinitol
|Nutrients|2021|21